Abbott has made the generous and mindful decision to make the FreeStyle Libre 14 Day system available in the U.S. for hospitalized patients with diabetes during the COVID-19 pandemic. Read the full press release here.
Key details from the press release include:
-- More than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized, according to a report from the Centers for Disease Control and Prevention (CDC).
-- FreeStyle Libre 14 day system can be used by frontline healthcare workers in hospitals to remotely monitor patients with diabetes who can scan to minimize exposure to COVID-19 and preserve use of personal protective equipment (PPE).
-- In partnership with the American Diabetes Association (ADA), Abbott will donate 25,000 FreeStyle Libre 14 day sensors to U.S. hospitals and medical centers in outbreak hotspots to help accelerate access to technology.